go back

Revefenacin (Yupelri) Inhalation Solution

Wyoming rates for HCPCS J7677

Revefenacin inhalation solution, FDA-approved final product, noncompounded, administered through DME, 1 mcg

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$00%20%10th90th$0Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.1$0.1$0.2$0.5

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.20
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.20
Typical High
$0.20
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.32
Median
$0.38
Typical High
$0.38
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.36
Median
$0.36
Typical High
$0.72
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.20
Median
$0.28
Typical High
$0.31
United
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.08
Typical High
$0.43
United
Setting
Professional
Modifier
Global
Typical Low
$0.08
Median
$0.20
Typical High
$0.20